Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement
Study Details
Study Description
Brief Summary
Labor pain is a major factor in making the placement of an epidural catheter difficult. The epidural, once in place and dosed, eventually decreases the parturient's pain. To achieve this goal as fast and safely as possible it would be helpful to have a parturient who can tolerate and co-operate with the placement of the epidural catheter.
Briefly stopping contractions, the cause of labor pain, could be the key to achieve this goal.
This study will evaluate the safety, efficacy and duration of the drug terbutaline for this purpose.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Terbutaline Terbutaline 0.125mg i.v. x 1 dose prior to positioning for epidural placement; may repeat x1 PRN |
Drug: Terbutaline
|
Active Comparator: Fentanyl Fentanyl 100mcg i.v. x 1 dose prior to positioning for epidural placement; may repeat x1 PRN |
Drug: Fentanyl
|
Placebo Comparator: Placebo 0.9% NaCl i.v. x 1 dose prior to positioning for epidural placement; may repeat x1 PRN |
Drug: 0.9% NaCl
Other Names:
|
Outcome Measures
Primary Outcome Measures
- reduction of pain score on a visual analog scale (VAS) of 1-10 [0-30 minutes]
semi-quantitative assessment of decrease in the subject's pain score after administration of the study drug for the placement of an epidural catheter
Secondary Outcome Measures
- movement during epidural placement [0-30 minutes]
semi-quantitative assessment of the subject's movement during placement of the epidural catheter: 0-1-2-3: none - extremities - trunk a bit - trunk a lot
- position during epidural placement [0-30 minutes]
semi-quantitative assessment of the subject's position during the epidural catheter placement: 0-1-2: excellent - moderate - poor
Other Outcome Measures
- hemodynamic and oxygenation assessment of parturient and fetus, side effects [0-30 minutes]
heart rate (HR), non-invasive blood pressure (NIBP), pulse-oximetry (SpO2), fetal heart rate (FHR), uterine contractions (CTG - cardiotocogram); feeling of being jittery, pruritus and nausea
Eligibility Criteria
Criteria
Inclusion Criteria:
-
in labor
-
labor pain >3 on visual analog scale (VAS)
Exclusion Criteria:
-
cardiovascular disease
-
preeclampsia
-
diabetes mel-litus
-
thyroid disease
-
current (outpatient) opioid medication
-
recent and / or current use of cocaine
-
seizure disorder
-
psychiatric disease
-
body mass index >35
-
preterm labor (<37 weeks pregnant)
-
known allergies to any of the three study substances
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Tucson Medical Center | Tucson | Arizona | United States | 85712 |
2 | University of Arizona Medical Center | Tucson | Arizona | United States | 85724 |
Sponsors and Collaborators
- Kai Schoenhage
Investigators
- Principal Investigator: Kai Schoenhage, MD, University of Arizona
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 12-0412